{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:16:15Z","timestamp":1795029375235,"version":"4.10.2"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016338","name":"Imperial Experimental Cancer Medicine Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019715","name":"Norsk institutt for naturforskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR304727"],"award-info":[{"award-number":["NIHR304727"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007568","name":"Urology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.eururo.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:58:49Z","timestamp":1783742329000},"page":"479-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-3651","authenticated-orcid":false,"given":"Alexander","family":"Light","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranil Johann","family":"Boaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manit","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Bertoncelli","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Dudderidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Emberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Grey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Laniado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McCraken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Noureldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Orczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnas","family":"Rakauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspal","family":"Virdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Withington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paimaun","family":"Zakikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim U.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taimur T.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2026.05.007_b0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2026.05.007_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0015","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.eururo.2026.05.007_b0020","article-title":"MP73-03 the proportion of patients eligible for focal therapy of non-metastatic prostate cancer in The Modern MRI-directed diagnostic pathway","volume":"209","author":"Reddy","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0025","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.euo.2025.02.003","article-title":"Outcomes of focal therapy for localized prostate cancer: a systematic review and meta-analysis of prospective studies","volume":"8","author":"\u015alusarczyk","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2026.05.007_b0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41391-020-00315-y","article-title":"Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study","volume":"24","author":"Shah","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2026.05.007_b0035","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41391-021-00369-6","article-title":"Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control","volume":"24","author":"van Son","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2026.05.007_b0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","article-title":"A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eururo.2018.12.030","article-title":"Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry","volume":"76","author":"Shah","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","article-title":"Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience","volume":"81","author":"Reddy","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cct.2013.06.005","article-title":"A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: the INDEX study","volume":"36","author":"Dickinson","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.eururo.2026.05.007_b0060","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.eururo.2014.01.001","article-title":"Focal therapy in prostate cancer: international multidisciplinary consensus on trial design","volume":"65","author":"van den Bos","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","article-title":"Focal therapy: patients, interventions, and outcomes\u2014a report from a consensus meeting","volume":"67","author":"Donaldson","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.105999","article-title":"Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): a prospective, multi-centre therapeutic phase II parallel Randomised Control Trial","volume":"93","author":"Reddy","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.eururo.2026.05.007_b0075","first-page":"17","article-title":"Transurethral water vapor ablation: potential for a novel prostate cancer management strategy","author":"Warlick","year":"2025","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/bju.15004","article-title":"Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry","volume":"125","author":"Lovegrove","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2026.05.007_b0085","unstructured":"Prostate Cancer - Uroweb uroweb.org\/guidelines\/prostate-cancer. Accessed 21\/01\/2026."},{"key":"10.1016\/j.eururo.2026.05.007_b0090","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.euf.2021.04.008","article-title":"Long-term outcomes of focal cryotherapy for low- to intermediate-risk prostate cancer: results and matched pair analysis with active surveillance","volume":"8","author":"Marra","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2026.05.007_b0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5489\/cuaj.3288","article-title":"Population-based 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia","volume":"9","author":"Peacock","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2026.05.007_b0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euros.2021.01.011","article-title":"Comparative survival outcomes of high-risk prostate cancer treated with radical prostatectomy or definitive radiotherapy regimens","volume":"26","author":"Aas","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2026.05.007_b0105","doi-asserted-by":"crossref","first-page":"12589","DOI":"10.1038\/s41598-022-16395-w","article-title":"Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study","volume":"12","author":"Su\u00e1rez","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2026.05.007_b0110","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/cncr.34916","article-title":"Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system","volume":"129","author":"Herr","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2026.05.007_b0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.euo.2023.08.005","article-title":"Prostate cancer-specific and all-cause mortality after robot-assisted radical prostatectomy: 20 years\u2019 report from the European Association of Urology robotic urology section Scientific Working Group","volume":"7","author":"Falagario","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2026.05.007_b0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eururo.2023.09.024","article-title":"Long-term prostate cancer\u2013specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer","volume":"85","author":"Herlemann","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.urology.2023.10.018","article-title":"National long-term survival estimates after radical prostatectomy for prostate cancer","volume":"184","author":"Stensland","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2026.05.007_b0130","doi-asserted-by":"crossref","first-page":"930.e23","DOI":"10.1016\/j.urolonc.2020.06.022","article-title":"Radiotherapy after radical prostatectomy: effect of timing of postprostatectomy radiation on functional outcomes","volume":"38","author":"Huelster","year":"2020","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.eururo.2026.05.007_b0135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/0284186X.2020.1759824","article-title":"Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study","volume":"59","author":"Draulans","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2026.05.007_b0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2026.05.007_b0145","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2014.09.028","article-title":"The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy","volume":"67","author":"Zumsteg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0150","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00345-016-1823-5","article-title":"Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer","volume":"34","author":"Fu","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2019.03.007","article-title":"Robot-assisted radical prostatectomy after focal therapy: oncological, functional outcomes and predictors of recurrence","volume":"76","author":"Marconi","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0160","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/bju.15432","article-title":"Outcomes of the RAFT trial: robotic surgery after focal therapy","volume":"128","author":"Cathcart","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2026.05.007_b0165","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.clon.2021.10.012","article-title":"Comparative effectiveness analyses of salvage prostatectomy and salvage radiotherapy outcomes following focal or whole-gland ablative therapy (high-intensity focused ultrasound, cryotherapy or electroporation) for localised prostate cancer","volume":"34","author":"Nathan","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.eururo.2026.05.007_b0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.euf.2023.01.013","article-title":"Salvage radical prostatectomy for recurrent prostate cancer after primary nonsurgical treatment: an updated systematic review","volume":"9","author":"Marra","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2026.05.007_b0175","doi-asserted-by":"crossref","first-page":"449.e1","DOI":"10.1016\/j.urolonc.2024.08.011","article-title":"Salvage local treatment for recurrent prostate cancer after focal therapy: a systematic review and meta-analysis","volume":"42","author":"Takemura","year":"2024","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.eururo.2026.05.007_b0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bju.14900","article-title":"Comparison of outcomes of salvage robot-assisted laparoscopic prostatectomy for post-primary radiation vs focal therapy","volume":"125","author":"Onol","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2026.05.007_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/bco2.70019","article-title":"The outcomes of salvage robotic radical prostatectomy following radiation versus focal therapy: does the primary treatment modality matter?","volume":"6","author":"Ghoreifi","year":"2025","journal-title":"BJUI Compass"},{"key":"10.1016\/j.eururo.2026.05.007_b0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/cancers17030396","article-title":"Patient-reported outcome measures and decision regret after salvage radical prostatectomy for recurrent prostate cancer following radiotherapy or focal therapy","volume":"17","author":"Falkenbach","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.eururo.2026.05.007_b0195","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaoncol.2025.6448","article-title":"Salvage focal therapy vs radical prostatectomy for localized Radiorecurrent prostate cancer","volume":"12","author":"Light","year":"2026","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2026.05.007_b0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22520","article-title":"Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT","volume":"22","author":"Hamdy","year":"2018","journal-title":"Health Technol Assess"},{"issue":"Suppl 4","key":"10.1016\/j.eururo.2026.05.007_b0210","article-title":"LBA03-07 imperial PROSTATE-4 comparative healthcare research outcomes of novel surgery in prostate cancer (IP4-CHRONOS): early feasibility, safety and functional outcomes from a pilot RCT","volume":"209","author":"Reddy","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0215","doi-asserted-by":"crossref","DOI":"10.1097\/01.JU.0001109960.86805.2e.01","article-title":"PD. 19\u201301 final, three-year oncological results of a randomized clinical trial FARP comparing focal ablation and radical prostatectomy in patients with unilateral clinically significant prostate cancer","volume":"213","author":"Baco","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.euo.2025.05.010","article-title":"Combination cytoreductive surgery, radiotherapy, or ablation for de novo metastatic prostate cancer: the IP2-ATLANTA internal pilot, Phase 2, randomised controlled trial","volume":"9","author":"Connor","year":"2026","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2026.05.007_b0225","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/JU.0000000000000747","article-title":"Prostate specific antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of nonmetastatic Prostate Cancer Using High Intensity Focused ultrasound","volume":"203","author":"Huber","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eururo.2020.04.068","article-title":"The role of percentage of prostate-specific antigen reduction after focal therapy using high-intensity focused ultrasound for primary localised prostate cancer. Results from a large multi-institutional series","volume":"78","author":"Stabile","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2024.02.001","article-title":"The transatlantic recommendations for prostate gland evaluation with magnetic resonance imaging after focal therapy (TARGET): a systematic review and international consensus recommendations","volume":"85","author":"Light","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.007_b0240","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euo.2023.04.007","article-title":"Prostate imaging after focal ablation (PI-FAB): a proposal for a scoring system for multiparametric MRI of the prostate after focal therapy","volume":"6","author":"Giganti","year":"2023","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382602169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382602169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:44:14Z","timestamp":1793825054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228382602169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S030228382602169X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2026.05.007","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}